Showing results (831-840 of 1,047) with videos related to

Sort By:
Pageof 105
Biological Reviews of the Cambridge Philosophical Society|June 10, 2024
The environment to the rescue: can physics help predict predator-prey interactions?Mehdi Cherif, Ulrich Brose, Myriam R Hirt, et al.
Neuron|September 17, 2009
Neuroligin 2 drives postsynaptic assembly at perisomatic inhibitory synapses through gephyrin and collybistinAlexandros Poulopoulos, Gayane Aramuni, Guido Meyer, et al.
The Lancet. Oncology|July 8, 2021
Cabozantinib for radioiodine-refractory differentiated thyroid cancer (COSMIC-311): a randomised, double-blind, placebo-controlled, phase 3 trialMarcia S Brose, Bruce Robinson, Steven I Sherman, et al.
Trials|July 3, 2023
Enhancing educational and vocational recovery in adolescents and young adults with early psychosis through Supported Employment and Education (SEEearly): study protocol for a multicenter randomized controlled trialD Jäckel, A Willert, A Brose, et al.
Public Health Research (Southampton, England)|April 21, 2026
The impact of vaping and smoking on nicotine intake and toxicant exposure among youth in England compared with youth in North AmericaAnn McNeill, Deborah Robson, David Hammond, et al.
Science (New York, N.Y.)|February 13, 2010
Doc2b is a high-affinity Ca2+ sensor for spontaneous neurotransmitter releaseAlexander J Groffen, Sascha Martens, Rocío Díez Arazola, et al.
Thyroid : Official Journal of the American Thyroid Association|December 8, 2023
Increased Progression-Free Survival with Cabozantinib Versus Placebo in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Irrespective of Prior Vascular Endothelial Growth Factor Receptor-Targeted Therapy and Tumor Histology: A Subgroup Analysis of the COSMIC-311 StudyJaume Capdevila, Jolanta Krajewska, Jorge Hernando, et al.
Molecular Biology of the Cell|November 19, 2004
Munc13-4 is an effector of rab27a and controls secretion of lysosomes in hematopoietic cellsMaaike Neeft, Marnix Wieffer, Arjan S de Jong, et al.
International Journal of Occupational Safety and Ergonomics : JOSE|February 20, 2024
Proposal and practicality of an alternative blue-light hazard risk assessment method for high-intensity white-light sources at workplacesStefan Bauer, Maxime Berget, Massimo Borra, et al.
The Journal of Clinical Endocrinology and Metabolism|October 19, 2021
A Randomized Study of Lenvatinib 18 mg vs 24 mg in Patients With Radioiodine-Refractory Differentiated Thyroid CancerMarcia S Brose, Yury Panaseykin, Bhavana Konda, et al.
Pageof 105